Lifecome Biochemistry 绿康生化
6 significant filings since 30 May 2026: 3 on acquisition or disposal, 1 on major holder selling and 1 on earnings pre-announcement, and 1 other kind. The latest, on 27 Aug 2026: 关于出售福建绿安生物农药有限公司股权的进展公告. 1 unverified report logged, the latest on 10 Aug 2026.
自 30 May 2026 起有 6 份重大公告：acquisition or disposal 3 份、major holder selling 1 份、earnings pre-announcement 1 份，另有 1 类。最新一份（27 Aug 2026）：关于出售福建绿安生物农药有限公司股权的进展公告。记录了 1 条未经核实的报道，最新一条见于 10 Aug 2026。
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥35亿 | ¥39亿 | 5th lowest of 12 · 12 家中第 5 低 | |
| Trailing P/E 市盈率 | — | 48.6x | No value 无数据 | |
| P/B 市净率 | 49.1x | 2.1x | Highest of 12 · 12 家中第 1 高 | |
| Revenue Growth 营收增速 | -15.7% | 0.0% | 3rd lowest of 12 · 12 家中第 3 低 | |
| Profit Growth 净利增速 | 112.5% | -36.2% | Highest of 12 · 12 家中第 1 高 | |
| Gross Margin 毛利率 | 22.9% | 38.8% | 3rd lowest of 12 · 12 家中第 3 低 | |
| Net Margin 净利率 | 2.8% | 8.3% | 5th lowest of 12 · 12 家中第 5 低 | |
| Return on Equity 净资产收益率 | 10.9% | 2.3% | Highest of 12 · 12 家中第 1 高 | |
| Debt to Assets 资产负债率 | 90.1% | 23.4% | Highest of 12 · 12 家中第 1 高 | |
| Grade Score 评级得分 | 54 | 54 | 6th lowest of 12 · 12 家中第 6 低 |
Statement figures are for the period to 30 Jun 2026, filed by 12 of 12 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，12 家同业中 12 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Jinyu 生物股份 | ¥125亿 | 87.2x | 2.3x | 22.1% | 14.7% | 1.9% | C |
| Tianjin Ringpu Bio-Technology 瑞普生物 | ¥77亿 | 22.2x | 1.6x | 0.8% | 12.9% | 4.3% | C |
| China Animal Husbandry 中牧股份 | ¥68亿 | 48.6x | 1.2x | 13.5% | 2.3% | 0.9% | D |
| Keqian Biology 科前生物 | ¥57亿 | 18.1x | 1.4x | -23.3% | 30.7% | 2.8% | C |
| Jinhe Biotechnology 金河生物 | ¥43亿 | 210.0x | 1.7x | 4.1% | 9.3% | 5.7% | C |
| Wuhan HVSEN Biotechnology 回盛生物 | ¥42亿 | 12.3x | 1.8x | 5.2% | 23.9% | 9.1% | C |
| Pulike 普莱柯 | ¥35亿 | 24.1x | 1.4x | -12.2% | 13.0% | 3.0% | C |
| Lifecome Biochemistry 绿康生化 | ¥35亿 | — | 49.1x | -15.7% | 2.8% | 10.9% | C |
| Shen Lian Biomedical 申联生物 | ¥34亿 | — | 2.5x | -8.1% | -18.2% | -1.4% | D |
| Winsunbio 永顺生物 | ¥18亿 | 64.0x | 2.7x | -28.1% | 7.3% | 0.9% | D |
| Drive 驱动力 | ¥11亿 | 460.9x | 4.6x | -0.8% | -1.6% | -0.2% | D |
| Dayu Biological 大禹生物 | ¥6.96亿 | — | 2.9x | 15.7% | -36.9% | -10.6% | E |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。